MiRXES Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $40M
Latest Deal Amount
  • Investors
  • 3

MiRXES General Information


Developer of a diagnostic test platform intended to detect cancer at an asymptomatic stage. The company's platform specializes in providing clinical diagnostic tools that seek to recognize early cancer detection in clinical examinations with its microRNA quantification test, enabling healthcare professionals to identify cancer at early stages and start rehabilitation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • 2 Tukang Innovation Grove
  • JTC MedTech Hub, Number 08-01
  • 618305
  • Singapore
+65 6816 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MiRXES Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 11-Jul-2018 $40M 0000 Completed Generating Revenue
2. Grant 09-Mar-2016 0000.00 Completed Generating Revenue
1. Early Stage VC 01-Jan-2016 Completed Generating Revenue

MiRXES Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Asuragen Venture Capital-Backed Austin, TX 000 000.00 00000000000 000.00
000000000 00000000 Formerly PE-Backed Syracuse, NY 00 000000&0

MiRXES Executive Team (7)

Name Title Board Seat Contact Info
Lihan Zhou Ph.D Co-Founder & Chief Executive Officer
Ruiyang Zou Ph.D Co-Founder, President and Chief Technology Officer
Abel Tiong Executive
JS Ong Executive
Sarah Ho Co-Founder

1 Former Executive

MiRXES Board Members (1)

Name Representing Role Since
Too Heng-Phon Ph.D Self Co-Founder & Chairman 000 0000

MiRXES Investors (3)

To view MiRXES‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Gaorong Capital Venture Capital Minority 000 0000 000000 0
Molecular Med Tri-Con Other 000 0000 000000 0
MiRXES Innovation Venture Capital Minority 000 0000 000000 0

MiRXES Investments (1)

To view MiRXES‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 (0000000000 00 01-Jan-2018 00000 0000000 Diagnostic Equipment 0000000 000 00.0

Ready to get started?

Request a free trial